Antibody-dependent enhancement of HSV-1 infection by anti-gK sera (Q40858984)

24 September 2017

Antibody-dependent enhancement of HSV-1 infection by anti-gK sera (English)

1 reference

Herpes simplex virus type 1

24 September 2017

1 reference

Ghiasi H

1

1 reference

24 September 2017

Perng GC

series ordinal

2

1 reference

24 September 2017

Nesburn AB

series ordinal

3

1 reference

24 September 2017

Wechsler SL

series ordinal

4

1 reference

24 September 2017

1 July 2000

1 reference

24 September 2017

1 reference

24 September 2017

68

1 reference

24 September 2017

137-144

1 reference

24 September 2017

2

1 reference

Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Antibody-mediated early death in vivo after infection with yellow fever virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Ocular herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Herpes simplex eye infections: clinical manifestations, pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

The US5 open reading frame of herpes simplex virus type 1 does encode a glycoprotein (gJ).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Acute rabies death mediated by antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2800%2900165-9

7 January 2021

10.1016/S0168-1702(00)00165-9

Identifiers

DOI

1 reference

release_j6vixw52vnfljpeoczburu6i6q

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j6vixw52vnfljpeoczburu6i6q

24 November 2022

mapped directly with Wikidata item

1 reference